Saturday - August 2, 2025
Ropes & Gray Advises Matchpoint Therapeutics in Novartis Option and License Agreement Worth Up to $1 Billion
July 24, 2025
BOSTON, Massachusetts, July 24 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:

* * *

Ropes & Gray Advises Matchpoint Therapeutics in Novartis Option and License Agreement Worth Up to $1 Billion

*

Ropes & Gray represented Matchpoint Therapeutics in an exclusive option and license agreement with Novartis for the development and commercialization of oral covalent inhibitors directed at a transcription fac . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products